ADDvise Group

1.72 SEK

0.00 %

Less than 1K followers

ADDV B

First North Stockholm

Medical Equipment & Services

Health Care

Overview

Financials & Estimates

Ownership

Investor consensus

0.00 %

+4.88 %

+6.04 %

+69.29 %

+16.53 %

-3.46 %

-68.31 %

+53.64 %

-17.61 %

ADDvise Group offers complete solutions for healthcare and research units, which include laboratory equipment, protective ventilation, and various consumables. The business is managed based on two business segments: Lab and Healthcare. The customers are found mainly in the Nordic market, but also in the rest of the international market and include both customers in the private and public sectors. The company is headquartered in Stockholm.

Market cap

1.04B SEK

Turnover

740.1K SEK

Revenue

-

EBIT %

-

P/E

3.25

Dividend yield-%

-

Revenue and EBIT-%

Revenue B

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar

12.2

2026

Annual report '25

29.4

2026

Interim report Q1'26

5.5

2026

General meeting '26

All

Webcasts

Press releases

ShowingAll content types

Regulatory press release15 hours ago

ADDvise has applied for delisting of its shares and warrants from Nasdaq First North

Regulatory press release17 hours ago

Notice of extraordinary general meeting in ADDvise Group AB (publ)

Regulatory press release1/14/2026, 3:50 PM

ADDvise announces financial update for 2025

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account

Followings and notifications on followed companies

Analyst comments and recommendations

Stock comparison tool & other popular tools

Regulatory press release1/13/2026, 9:30 PM

ADDvise receives the bondholders’ approval in the written procedure under its outstanding bonds 2025/2028

Regulatory press release1/5/2026, 5:22 PM

Statement from the independent bid committee of ADDvise in relation to the public offer from Amplex

Regulatory press release1/2/2026, 3:42 PM

ADDvise initiates a written procedure under its outstanding bonds 2025/2028 in light of the public offer from Amplex

Regulatory press release12/19/2025, 7:30 PM

Amplex has increased the consideration in the public offer to the shareholders and warrant holders of ADDVise

Regulatory press release12/10/2025, 6:35 AM

ADDvise’s board of directors evaluates the public offer from Amplex

Regulatory press release11/12/2025, 8:35 AM

ADDvise receives order worth USD 2.3 million

Regulatory press release11/5/2025, 4:00 PM

ADDvise Group’s nomination committee for the Annual General Meeting 2026

ADDvise Group, Audiocast, Q3'25

Webcast10/23/2025, 12:00 PM

ADDvise Group, Audiocast, Q3'25

Regulatory press release10/23/2025, 5:45 AM

Interim report 2025, January 1–September 30

Press release10/15/2025, 2:00 PM

Invitation to presentation of interim report January 1 – September 30, 2025

ADDvise Group, Audiocast, Q2'25

Webcast7/17/2025, 12:00 PM

ADDvise Group, Audiocast, Q2'25

Regulatory press release7/17/2025, 5:45 AM

ADDvise Group AB: Interim report 2025, January 1-June 30

Regulatory press release7/11/2025, 9:15 AM

ADDvise Group AB: ADDvise publishes prospectus and applies for admission to trading of bonds on Nasdaq Stockholm

Press release7/9/2025, 12:45 PM

ADDvise Group AB: Invitation to presentation of interim report April 1 - June 30, 2025

Regulatory press release5/28/2025, 11:11 AM

ADDvise Group AB: ADDvise announces that the conditions for early redemption of outstanding secured bonds have been fulfilled

Regulatory press release5/26/2025, 2:07 PM

ADDvise Group AB: ADDvise enters into facilities agreement with Nordea - reduces financial costs by approximately SEK 56 million per year

Regulatory press release5/20/2025, 11:10 AM

ADDvise Group AB: ADDvise announces the result of the tender offer regarding its outstanding senior secured bonds

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.